P
CRM
vs
W
WIG20
Over the past 12 months, CRM has underperformed WIG20, delivering a return of -28% compared to the WIG20's +28% growth.
Stocks Performance
CRM vs WIG20
Performance Gap
CRM vs WIG20
Performance By Year
CRM vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PZ Cormay SA
Glance View
PZ Cormay SA engages in the manufacture of diagnostic reagents and laboratory equipment. The company is headquartered in Lomianki, Woj. Mazowieckie and currently employs 218 full-time employees. The company went IPO on 2008-08-20. The firm is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. The company offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.
